Wednesday 27 May 2020

SGD Pharma to invest $22m in rebuilding furnace

PARIS, May 16, 2019

France-based SGD Pharma group has announced an investment of more than €20 million ($22.40 million) to rebuild its furnace and modernise the century-old Sucy-en-Brie project.

SGD Pharma is a provider of innovative and premium quality packaging solutions consistent with international pharmacopoeias.
The Sucy-en-Brie factory, 400 employees, has been dedicated to producing pharmaceutical bottles since 1917. The factory supplies syrups, droppers, tablets, injectable and infusion bottles to over 450 customers around the world and cover the following therapeutic areas: oral and parenteral antibiotics, parenteral nutrition, respiratory illness, pain-relievers, anaesthetics, and OTC, said a company statement.

Every year, 80,000 tonnes of Type II & III flint and amber moulded glass bottles are produced there, making this factory one of the biggest players in the European health care industry. Its 41,000 sq m surface includes ISO eight clean rooms, two furnaces, and eight production lines. The factory is ISO 15378 & 50001 certified.

After 12 years of operation, one furnace will be completely rebuilt, enlarged, and elevated to the same level as the second one. This work, which will require a change in the building’s superstructure, will allow a more economical operation with a 10 per cent reduction in energy consumption as well as a reduced environmental footprint with a 10 per cent decrease in emissions into the environment, it said.

The production lines will all be modernised with the latest technologies. Finally, newly acquired inspection line and control equipment will improve the detection of anomalies, it added.

Benefits for customers: An improvement in the industrial performance of the site delivering superior quality, increased production flexibility, and greater adaptation to market needs. The work, scheduled to begin in the summer of 2020, will take two months, during which SGD Pharma will rely on its other production sites to fulfil orders.

SGD Pharma continually strengthens its operational excellence to provide quality products, reliable service to its customers and ensure patient safety, it stated. – TradeArabia News Service


More Industry, Logistics & Shipping Stories

calendarCalendar of Events